De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

ICU Medical Beheer

Beheer criteriumcontroles 3/4

De CEO ICU Medical's is Vivek Jain, benoemd in Feb2014, heeft een ambtstermijn van 10.67 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 6.81M, bestaande uit 11.4% salaris en 88.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.79% van de aandelen van het bedrijf, ter waarde $ 35.22M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 6.8 jaar en 6.8 jaar.

Belangrijke informatie

Vivek Jain

Algemeen directeur

US$6.8m

Totale compensatie

Percentage CEO-salaris	11.4%
Dienstverband CEO	10.7yrs
Eigendom CEO	0.8%
Management gemiddelde ambtstermijn	6.8yrs
Gemiddelde ambtstermijn bestuur	6.8yrs

Recente managementupdates

Recent updates

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Oct 01

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry

Aug 18

ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly

Aug 07

ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult

Jun 27

ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price

Jun 23

Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

May 09

Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

Apr 26

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Mar 31

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

Jan 31

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

Jan 04

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

Oct 28

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Oct 07

ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M

Aug 08

FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious

Jul 20

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Jun 08

ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value

Mar 25

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Feb 23

Analyse CEO-vergoeding

Hoe is Vivek Jain's beloning veranderd ten opzichte van ICU Medical's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	-US$71m
Mar 31 2024	n/a	n/a	-US$59m
Dec 31 2023	US$7m	US$775k	-US$30m
Sep 30 2023	n/a	n/a	-US$28m
Jun 30 2023	n/a	n/a	-US$48m
Mar 31 2023	n/a	n/a	-US$46m
Dec 31 2022	US$6m	US$756k	-US$74m
Sep 30 2022	n/a	n/a	-US$39m
Jun 30 2022	n/a	n/a	US$5m
Mar 31 2022	n/a	n/a	US$41m
Dec 31 2021	US$5m	US$650k	US$103m
Sep 30 2021	n/a	n/a	US$109m
Jun 30 2021	n/a	n/a	US$103m
Mar 31 2021	n/a	n/a	US$94m
Dec 31 2020	US$3m	US$650k	US$87m
Sep 30 2020	n/a	n/a	US$81m
Jun 30 2020	n/a	n/a	US$83m
Mar 31 2020	n/a	n/a	US$87m
Dec 31 2019	US$3m	US$650k	US$101m
Sep 30 2019	n/a	n/a	US$73m
Jun 30 2019	n/a	n/a	US$47m
Mar 31 2019	n/a	n/a	US$55m
Dec 31 2018	US$6m	US$650k	US$29m
Sep 30 2018	n/a	n/a	US$86m
Jun 30 2018	n/a	n/a	US$86m
Mar 31 2018	n/a	n/a	US$18m
Dec 31 2017	US$4m	US$650k	US$69m

Compensatie versus markt: De totale vergoeding ($USD 6.81M ) Vivek } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.79M ).

Compensatie versus inkomsten: De vergoeding van Vivek is gestegen terwijl het bedrijf verliesgevend is.

CEO

Vivek Jain (52 yo)

10.7yrs

Tenure

US$6,810,975

Compensatie

Mr. Vivek Jain has been an Independent Director of Envista Holdings Corporation since April 07, 2020. Mr. Jain has been Chairman and Chief Executive Officer of ICU Medical, Inc. since February 13, 2014. Mr...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Vivek Jain	CEO & Chairman of the Board	10.7yrs	US$6.81m	0.79% $ 34.6m
Brian Bonnell	CFO & Treasurer	4.6yrs	US$4.39m	0.10% $ 4.5m
Christian Voigtlander	Chief Operating Officer	6.8yrs	US$4.40m	0% $ 0
Virginia Sanzone	Corporate VP	6.8yrs	US$2.47m	0.018% $ 802.9k

6.8yrs

Gemiddelde duur

51yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van ICUI is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Vivek Jain	CEO & Chairman of the Board	10.7yrs	US$6.81m	0.79% $ 34.6m
Elisha Finney	Independent Director	8.8yrs	US$265.14k	0.0087% $ 381.5k
Kolleen Kennedy	Independent Director	2.8yrs	US$255.14k	0.0064% $ 280.0k
David Hoffmeister	Independent Director	6.8yrs	US$282.14k	0.012% $ 542.1k
Laurie Hernandez	Independent Director	3.3yrs	US$255.14k	0.0077% $ 337.8k
David Greenberg	Lead Independent Director	9.3yrs	US$296.14k	0.023% $ 991.9k
Donald Abbey	Independent Director	6.8yrs	US$255.14k	0.012% $ 542.1k

6.8yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van ICUI wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.8 jaar).

ICU Medical Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

CEO & Chairman of the Board exercised options and sold US$1.1m worth of stock

CEO & Chairman of the Board exercised options and sold US$896k worth of stock

Insider recently sold US$408k worth of stock

CEO & Chairman of the Board exercised options and sold US$807k worth of stock

Insufficient new directors

Chief Operating Officer recently sold US$1.3m worth of stock

Recent updates

CEO & Chairman of the Board exercised options and sold US$1.1m worth of stock

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Price target increased by 7.6% to US$162

Price target increased by 10% to US$155

CEO & Chairman of the Board exercised options and sold US$896k worth of stock

Insider recently sold US$408k worth of stock

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry

CEO & Chairman of the Board exercised options and sold US$807k worth of stock

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ICU Medical, Inc. Updates Earnings Guidance for the Fiscal Year 2024

ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly

Insufficient new directors

ICU Medical, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Now 21% undervalued

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell 1000 Dynamic Index

ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult

ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price

Chief Operating Officer recently sold US$1.3m worth of stock

Consensus EPS estimates fall by 65%

Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ICU Medical, Inc. Provides Updated Unaudited Earnings Guidance for the Year 2024

Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

ICU Medical, Inc. to Report Q1, 2024 Results on May 07, 2024

ICU Medical, Inc., Annual General Meeting, May 15, 2024

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

CEO & Chairman of the Board exercised options and sold US$262k worth of stock

ICU Medical, Inc. Announces the Resignation of Bill Seeger as Nominated Director

Director notifies of intention to sell stock

Chief Operating Officer recently sold US$1.5m worth of stock

ICU Medical, Inc. Announces Resignation of William Seeger from Board of Director and Member of the Audit and Compliance Committee

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CEO & Chairman of the Board exercised options and sold US$5.4m worth of stock

ICU Medical, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from S&P 400 Health Care (Sector)

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 24% to US$154

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

ICU Medical, Inc. to Report Q3, 2023 Results on Nov 06, 2023

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Chief Operating Officer recently sold US$884k worth of stock

Chief Operating Officer notifies of intention to sell stock

ICU Medical Inc. Receives FDA Clearance for Plum Duo Infusion Pump and LifeShield Infusion Safety Software

Icu Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

ICU Medical, Inc. to Report Q2, 2023 Results on Aug 07, 2023

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Now 23% undervalued after recent price drop

CEO & Chairman of the Board notifies of intention to sell stock

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell Small Cap Comp Growth Index

Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

CEO & Chairman of the Board exercised options and sold US$3.9m worth of stock

First quarter 2023 earnings: EPS misses analyst expectations

Corporate VP notifies of intention to sell stock

Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt

CEO & Chairman of the Board exercised options and sold US$1.5m worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

ICU Medical, Inc. to Report Q4, 2022 Results on Feb 27, 2023

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Corporate VP notifies of intention to sell stock

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

ICU Medical, Inc. Reaffirms Earnings Guidance for the Full Year 2022

ICU Medical, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Director exercised options to buy US$12m worth of stock.

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical Hit Hard As Smiths Medical Needs Significant TLC